dr. Vanesa Gregorc Oncologo Specialista in Tumore al Polmone

Autoantibody positivity predicts severity of rheumatic immune-related adverse events to immune-checkpoint inhibitors.

Campochiaro C, Farina N, Tomelleri A, Ferrara R, Viola S, Lazzari C, De Luca G, Raggi D, Bulotta A, Matucci-Cerinic M, Necchi A, Garassino M, Gregorc V, Dagna L. Eur J Intern Med. 2022 Jul 9:S0953-6205(22)00253-9. doi: 10.1016/j.ejim.2022.07.005. Online ahead of print. PMID: 35821192

Corrigendum to “International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer”: [Annals of Oncology 33 (2022) 57-66].

Novello S, Torri V, Grohe C, Kurz S, Serke M, Wehler T, Meyer A, Ladage D, Geissler M, Colantonio I, Cauchi C, Stoelben E, Ceribelli A, Kropf-Sanchen C, Valmadre G, Borra G, Schena M, Morabito A, Santo A, Gregorc V, Chiari R, Reck M, Schmid-Bindert G, Folprecht G, Griesinger F, Follador A, Pedrazzoli P, Bearz A, Caffo O, Dickgreber NJ, Irtelli L, Wiest G, Monica V, Porcu L, Manegold C, Scagliotti GV. Ann Oncol. 2022 Apr;33(4):454. doi: 10.1016/j.annonc.2022.01.005. Epub 2022 Jan 25. PMID: 35086737 No abstract available.

Angiogenesis inhibition in lung cancer: emerging novel strategies.

Lazzari C, Bulotta A, Damiano G, Mirabile A, Viganó M, Veronesi G, Gregorc V. Curr Opin Oncol. 2022 Jan 1;34(1):107-114. doi: 10.1097/CCO.0000000000000807. PMID: 34812193 Review.

Abemaciclib in Combination With Pembrolizumab for Stage IV KRAS-Mutant or Squamous NSCLC: A Phase 1b Study.

Pujol JL, Vansteenkiste J, Paz-Ares Rodríguez L, Gregorc V, Mazieres J, Awad M, Jänne PA, Chisamore M, Hossain AM, Chen Y, Beck JT. JTO Clin Res Rep. 2021 Sep 25;2(11):100234. doi: 10.1016/j.jtocrr.2021.100234. eCollection 2021 Nov. PMID: 34746886 Free PMC article.

Immunotherapeutic Advances for NSCLC.

Massafra M, Passalacqua MI, Gebbia V, Macrì P, Lazzari C, Gregorc V, Buda C, Altavilla G, Santarpia M. Biologics. 2021 Oct 8;15:399-417. doi: 10.2147/BTT.S295406. eCollection 2021. PMID: 34675481 Free PMC article. Review.

International Tailored Chemotherapy Adjuvant (ITACA) trial, a phase III multicenter randomized trial comparing adjuvant pharmacogenomic-driven chemotherapy versus standard adjuvant chemotherapy in completely resected stage II-IIIA non-small-cell lung cancer.

Novello S, Torri V, Grohe C, Kurz S, Serke M, Wehler T, Meyer A, Ladage D, Geissler M, Colantonio I, Cauchi C, Stoelben E, Ceribelli A, Kropf-Sanchen C, Valmadre G, Borra G, Schena M, Morabito A, Santo A, Gregorc V, Chiari R, Reck M, Schmid-Bindert G, Folprecht G, Griesinger F, Follador A, Pedrazzoli P, Bearz A, Caffo O, Dickgreber NJ, Irtelli L, Wiest G, Monica V, Porcu L, Manegold C, Scagliotti GV. Ann Oncol. 2022 Jan;33(1):57-66. doi: 10.1016/j.annonc.2021.09.017. Epub 2021 Oct 5. PMID: 34624497 Clinical Trial.

Tocilizumab for the treatment of immune-related adverse events: a systematic literature review and a multicentre case series.

Campochiaro C, Farina N, Tomelleri A, Ferrara R, Lazzari C, De Luca G, Bulotta A, Signorelli D, Palmisano A, Vignale D, Peretto G, Sala S, Esposito A, Garassino M, Gregorc V, Dagna L. Eur J Intern Med. 2021 Nov;93:87-94. doi: 10.1016/j.ejim.2021.07.016. Epub 2021 Aug 12. PMID: 34391591

Role of stereotactic radiosurgery for the treatment of brain metastasis in the era of immunotherapy: A systematic review on current evidences and predicting factors.

Gagliardi F, De Domenico P, Snider S, Roncelli F, Pompeo E, Barzaghi LR, Bulotta A, Gregorc V, Lazzari C, Cascinu S, Finocchiaro G, Mortini P. Crit Rev Oncol Hematol. 2021 Sep;165:103431. doi: 10.1016/j.critrevonc.2021.103431. Epub 2021 Jul 27. PMID: 34324961 Review.

Lung cancer screening: who pays? Who receives? The European perspectives.

Novellis P, Cominesi SR, Rossetti F, Mondoni M, Gregorc V, Veronesi G. Transl Lung Cancer Res. 2021 May;10(5):2395-2406. doi: 10.21037/tlcr-20-677. PMID: 34164287 Free PMC article. Review.

Venoarterial Extracorporeal Membrane Oxygenation Support in Lung Cancer Resection.

Novellis P, Monaco F, Landoni G, Rossetti F, Carretta A, Gregorc V, Zangrillo A, Veronesi G. Ann Thorac Surg. 2022 Mar;113(3):e191-e193. doi: 10.1016/j.athoracsur.2021.05.040. Epub 2021 Jun 8. PMID: 34111383

dr.ssa Vanesa Gregorc

Biografia

Link utili

Pubblicazioni scientifiche recenti

Con il supporto incondizionato di

Neoplasie toraciche

Diagnosi

Terapie

Affrontare la malattia

Chi siamo